Back to search

Ireland· IE-PA-PPA1463/143/001

Regurin 20 mg coated tablets

A trospium product containing trospium chloride, registered in Ireland by IMED Healthcare Ltd.,. The same ATC class is registered in 9 of our 19 countries.

ATC G04BD09

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedRegurin 20 mg coated tabletsATCG04BD09REGISTER NO.IE-PA-PPA1463/143/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Trospium is registered in 9 of 19 countries.

Countries holding a registration under ATC G04BD09 (trospium), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 4 of them publish a price we can compare per daily dose

Trospium · ATC G04BD09

9 / 19 countries

  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of trospium costs, country by country.

Normalised to the WHO defined daily dose (40 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Trospium · price per daily dose (40 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.71
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Trospium chloride
Manufacturer
IMED Healthcare Ltd.,
Country
Ireland (IE)
ATC code
G04BD09
ATC class
Trospium
Defined daily dose
40 mg, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PPA1463/143/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

254 interactions on record for trospium.

Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Trospium · interactions on record

254 records

  • 6 severe
  • 202 moderate
  • 13 minor

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • TopiramatN02CX12severe

33 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Trospium in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trospium products

Authorised across Europe · EMA

The same active substance is authorised in 18 EEA countries. Names it is sold under:

  • Austria · Inkontan, Spasmolyt
  • Bulgaria · Инконтан, Спазмо-Лит
  • Czechia · Spasmed, Uraplex
  • Germany · Spasmex, Spasmex Tc
  • Denmark · Spasmo-Lyt, Spasmo-Lyt Depot
  • Estonia · Spasmed
  • Spain · Uraplex
  • Finland · Spasmo-Lyt Depot, Spasmo-Lyt Plus
  • France · Ceris, Chlorure De Trospium Viatris
  • United Kingdom (Northern Ireland) · Regurin, Regurin Xl
  • Croatia · Spasmex
  • Hungary · Descalon
  • Italy · Urivesc
  • Luxembourg · Spasmex, Spasmo-Urgenin Tc
  • Portugal · Cloreto De Tróspio Farmoz, Cloreto De Tróspio Generis
  • Romania · Inkontan
  • Slovenia · Spasmex
  • Slovakia · Spasmed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b8fde3be-d893-4a10-ad69-aa6030221694
GET /v1/drugs/b8fde3be-d893-4a10-ad69-aa6030221694?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Coated tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "G04BD",
    "G04BD09"
  ],
  "strength": null,
  "pa_number": "PPA1463/143/001",
  "substances": [
    "Trospium chloride"
  ],
  "legal_basis": "Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC",
  "market_info": "Unknown",
  "authorised_at": "23/11/2007",
  "dispensing_status": "Product subject to prescription which may be renewed (B)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about trospium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.